PubMed ID:
26948990
Public Release Type:
Journal
Publication Year: 2016
DOI:
https://doi.org/10.1053/j.ajkd.2016.01.015
Authors:
Foster Meredith C., Coresh Josef, Hsu Chi-yuan, Xie Dawei, Levey Andrew S., Nelson Robert G., Eckfeldt John H., Vasan Ramachandran S., Kimmel Paul L., Schelling Jeffrey, Simonson Michael, Sondheimer James H., Anderson Amanda Hyre, Akkina Sanjeev, Feldman Harold I., Kusek John W., Ojo Akinlolu O., Inker Lesley A.
Request IDs:
20522
Studies:
African American Study of Kidney Disease and Hypertension Study (Clinical Trial)
Serum β-trace protein (BTP) and β2-microglobulin (B2M) are independently associated with end-stage renal disease (ESRD) and mortality in the general population and high-risk groups with diabetes or advanced chronic kidney disease (CKD). Less is known about their associations with outcomes and predictive ability in adults with moderate CKD.